Form 4: Dentsply Sirona Director Leslie F. Varon Reports Acquisition of Restricted Stock Units

Sentiment:

SEC Form 4 Filing


Leslie F. Varon, a director at Dentsply Sirona Inc., reported the acquisition of 7,994 Restricted Stock Units (RSUs) on May 23, 2024.

Summary

  • On May 23, 2024, Leslie F. Varon, a director of Dentsply Sirona Inc. [XRAY], acquired 7,994 shares of Common Stock in the form of Restricted Stock Units (RSUs).
  • The RSUs were granted at a price of $0.
  • These RSUs vest in full one year from the date of grant.
  • Following the transaction, Varon directly owns 33,552.303 shares of Dentsply Sirona Inc.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a routine disclosure of stock grants to a director. It indicates alignment of interests but doesn't necessarily imply strong positive or negative outlook.

Positives

  • The acquisition of RSUs by a director signals confidence in the company's future performance.

Future Outlook

The RSUs vest in one year, suggesting a commitment to the company's performance over that period.

Industry Context

Insider transactions are closely watched as indicators of management's perspective on the company's valuation and prospects within the dental and medical device industry.

Comparison to Industry Standards

  • Comparing insider ownership and RSU grants to peers like Align Technology (ALGN) or Envista Holdings (NVST) can provide context on executive compensation and alignment with shareholder interests.
  • Benchmarking the vesting schedule against industry norms for equity compensation can also be informative.

Stakeholder Impact

  • The transaction could have a minor positive impact on shareholder sentiment due to the alignment of director interests with shareholders.

Key Dates

DateDescription
05/23/2024Date of transaction: acquisition of Restricted Stock Units
05/24/2024Date of signature by Attorney-In-Fact

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.